People talk as if AI will suddenly make drug discovery cheap and easy. Why is that view incomplete?
Replied byDave Ricks
Chair & CEO at Eli Lilly and Company
Niche: Pharmaceuticals, AI, Health & Wellness
Revenue: $1M+/month
Location: USA
Started: 2015 or
AI can find targets, propose molecules, and flag some toxicity earlier. It makes the front end faster. But you still have to test drugs in real people across many countries over long periods. Most cost and time sits in rigorous clinical trials, so AI improves odds but does not erase the need for careful testing.
0
From the Full Interview
This answer is part of a full interview with Dave Ricks, Chair & CEO at Eli Lilly and Company.
Share this Answer
Found this insight valuable? Share it with your network to help others learn from Dave Ricks's experience.
Cite This Answer
Use this answer in your research, article, or academic work
Related Answers
Why did you decide to create your own brands?
By Paul Guyett
Retail
$1M+/mo
What role does training play in your company?
By Paul Guyett
Retail
$1M+/mo
How does sustainability influence your decisions?
By Paul Guyett
Retail
$1M+/mo
What advice would you give to someone building a long-term business?
By Paul Guyett
Retail
$1M+/mo
Can you tell us how the business started and what that means to you today?
By Paul Guyett
Retail
$1M+/mo
How has the business evolved over the years?
By Paul Guyett
Retail
$1M+/mo
What leadership lesson stands out from managing a long-established company?
By Paul Guyett
Retail
$1M+/mo